SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-21-008868
Filing Date
2021-09-20
Accepted
2021-09-20 20:29:47
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 4222
  Complete submission text file 0001179110-21-008868.txt   5898
Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
Pellizzari Christine A (Reporting) CIK: 0001127430 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35890 | Film No.: 211264512

Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations